131 related articles for article (PubMed ID: 28970066)
1. FOXO1 reduces tumorsphere formation capacity and has crosstalk with LGR5 signaling in gastric cancer cells.
Choi Y; Park J; Ko YS; Kim Y; Pyo JS; Jang BG; Kim MA; Lee JS; Chang MS; Lee BL
Biochem Biophys Res Commun; 2017 Nov; 493(3):1349-1355. PubMed ID: 28970066
[TBL] [Abstract][Full Text] [Related]
2. Loss of FOXO1 promotes gastric tumour growth and metastasis through upregulation of human epidermal growth factor receptor 2/neu expression.
Ko YS; Cho SJ; Park J; Kim Y; Choi YJ; Pyo JS; Jang BG; Park JW; Kim WH; Lee BL
Br J Cancer; 2015 Oct; 113(8):1186-96. PubMed ID: 26448177
[TBL] [Abstract][Full Text] [Related]
3. Forkhead Transcription Factor FOXO1 Inhibits Angiogenesis in Gastric Cancer in Relation to SIRT1.
Kim SY; Ko YS; Park J; Choi Y; Park JW; Kim Y; Pyo JS; Yoo YB; Lee JS; Lee BL
Cancer Res Treat; 2016 Jan; 48(1):345-54. PubMed ID: 25761483
[TBL] [Abstract][Full Text] [Related]
4. LGR5 Is a Gastric Cancer Stem Cell Marker Associated with Stemness and the EMT Signature Genes NANOG, NANOGP8, PRRX1, TWIST1, and BMI1.
Wang B; Chen Q; Cao Y; Ma X; Yin C; Jia Y; Zang A; Fan W
PLoS One; 2016; 11(12):e0168904. PubMed ID: 28033430
[TBL] [Abstract][Full Text] [Related]
5. LncRNA ANCR Promotes Invasion and Migration of Gastric Cancer by Regulating FoxO1 Expression to Inhibit Macrophage M1 Polarization.
Xie C; Guo Y; Lou S
Dig Dis Sci; 2020 Oct; 65(10):2863-2872. PubMed ID: 31894487
[TBL] [Abstract][Full Text] [Related]
6. Upregulated miR-132 in Lgr5
Zhang L; Guo X; Zhang D; Fan Y; Qin L; Dong S; Zhang L
Mol Carcinog; 2017 Sep; 56(9):2022-2034. PubMed ID: 28383763
[TBL] [Abstract][Full Text] [Related]
7. Lgr5-Positive Cells are Cancer-Stem-Cell-Like Cells in Gastric Cancer.
Wang Z; Liu C
Cell Physiol Biochem; 2015; 36(6):2447-55. PubMed ID: 26279446
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of leucine-rich-repeat-containing G-protein-coupled receptor 5, an intestinal stem cell marker, in gastric carcinomas.
Jang BG; Lee BL; Kim WH
Gastric Cancer; 2016 Jul; 19(3):767-77. PubMed ID: 26386561
[TBL] [Abstract][Full Text] [Related]
9. Rspondin-1 contributes to the progression and stemness of gastric cancer by LGR5.
Wang C; Gao Y; Liang W; Lu Y; Zhang K; Wu D; Zhuang Z; Li K; Qiao Z; Xi H; Chen L
Biochem Biophys Res Commun; 2022 Oct; 627():91-96. PubMed ID: 36030657
[TBL] [Abstract][Full Text] [Related]
10. LGR5 promotes cancer stem cell traits and chemoresistance in cervical cancer.
Cao HZ; Liu XF; Yang WT; Chen Q; Zheng PS
Cell Death Dis; 2017 Sep; 8(9):e3039. PubMed ID: 28880275
[TBL] [Abstract][Full Text] [Related]
11. FOXO1 Suppression is a Determinant of Acquired Lapatinib-Resistance in HER2-Positive Gastric Cancer Cells Through MET Upregulation.
Park J; Choi Y; Ko YS; Kim Y; Pyo JS; Jang BG; Kim MA; Lee JS; Chang MS; Park JW; Lee BL
Cancer Res Treat; 2018 Jan; 50(1):239-254. PubMed ID: 28343375
[TBL] [Abstract][Full Text] [Related]
12. The Wnt/β-catenin pathway regulates self-renewal of cancer stem-like cells in human gastric cancer.
Cai C; Zhu X
Mol Med Rep; 2012 May; 5(5):1191-6. PubMed ID: 22367735
[TBL] [Abstract][Full Text] [Related]
13. Lgr5-expressing chief cells drive epithelial regeneration and cancer in the oxyntic stomach.
Leushacke M; Tan SH; Wong A; Swathi Y; Hajamohideen A; Tan LT; Goh J; Wong E; Denil SLIJ; Murakami K; Barker N
Nat Cell Biol; 2017 Jul; 19(7):774-786. PubMed ID: 28581476
[TBL] [Abstract][Full Text] [Related]
14. CircMRPS35 suppresses gastric cancer progression via recruiting KAT7 to govern histone modification.
Jie M; Wu Y; Gao M; Li X; Liu C; Ouyang Q; Tang Q; Shan C; Lv Y; Zhang K; Dai Q; Chen Y; Zeng S; Li C; Wang L; He F; Hu C; Yang S
Mol Cancer; 2020 Mar; 19(1):56. PubMed ID: 32164722
[TBL] [Abstract][Full Text] [Related]
15. RNAi-mediated inhibition of Lgr5 leads to decreased angiogenesis in gastric cancer.
Xi HQ; Zhang KC; Li JY; Cui JX; Gao YH; Wei B; Huang D; Chen L
Oncotarget; 2017 May; 8(19):31581-31591. PubMed ID: 28404940
[TBL] [Abstract][Full Text] [Related]
16. Nuclear PRMT1 expression is associated with poor prognosis and chemosensitivity in gastric cancer patients.
Altan B; Yokobori T; Ide M; Mochiki E; Toyomasu Y; Kogure N; Kimura A; Hara K; Bai T; Bao P; Suzuki M; Ogata K; Asao T; Nishiyama M; Oyama T; Kuwano H
Gastric Cancer; 2016 Jul; 19(3):789-97. PubMed ID: 26472729
[TBL] [Abstract][Full Text] [Related]
17. Regulatory T Cells Promote Overexpression of Lgr5 on Gastric Cancer Cells via TGF-beta1 and Confer Poor Prognosis in Gastric Cancer.
Liu XS; Lin XK; Mei Y; Ahmad S; Yan CX; Jin HL; Yu H; Chen C; Lin CZ; Yu JR
Front Immunol; 2019; 10():1741. PubMed ID: 31417548
[No Abstract] [Full Text] [Related]
18. c-Jun N-terminal kinase activation has a prognostic implication and is negatively associated with FOXO1 activation in gastric cancer.
Choi Y; Park J; Choi Y; Ko YS; Yu DA; Kim Y; Pyo JS; Jang BG; Kim MA; Kim WH; Lee BL
BMC Gastroenterol; 2016 Jun; 16(1):59. PubMed ID: 27268017
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical Analysis of LGR5 and TROY Expression in Gastric Carcinogenesis Demonstrates an Inverse Trend.
Saberi S; Piryaei A; Mirabzadeh E; Esmaeili M; Karimi T; Momtaz S; Abdirad A; Sodeifi N; Mohagheghi MA; Baharvand H; Mohammadi M
Iran Biomed J; 2019 Mar; 23(2):107-20. PubMed ID: 30501144
[TBL] [Abstract][Full Text] [Related]
20. LGR5 Promotes Breast Cancer Progression and Maintains Stem-Like Cells Through Activation of Wnt/β-Catenin Signaling.
Yang L; Tang H; Kong Y; Xie X; Chen J; Song C; Liu X; Ye F; Li N; Wang N; Xie X
Stem Cells; 2015 Oct; 33(10):2913-24. PubMed ID: 26086949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
